iCAD is trading at a lower price-to-earnings ratio than Endologix, indicating that it is currently the more affordable of the two stocks. Volatility and Risk iCAD has a beta of 1.18, suggesting that …
More Head to Head Comparison: Endologix (NASDAQ:ELGX) versus iCAD (NASDAQ:ICAD) Videos